Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways

被引:0
作者
Hadar Vinograd-Byk
Paul Renbaum
Ephrat Levy-Lahad
机构
[1] Shaare Zedek Medical Center,Medical Genetics Institute
[2] Hebrew University Medical School,undefined
来源
Scientific Reports | / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in Vaccinia-related kinase 1 (VRK1) have emerged as a cause of severe neuronal phenotypes in human, including brain developmental defects and degeneration of spinal motor neurons, leading to Spinal Muscular Atrophy (SMA) or early onset Amyotrophic Lateral Sclerosis (ALS). Vrk1 gene-trap partial Knockout (KO) mice (Vrk1GT3/GT3), which express decreased levels of Vrk1, are sterile due to impaired gamete production. Here, we examined whether this mouse model also presents neuronal phenotypes. We found a 20–50% reduction in Vrk1 expression in neuronal tissues of the Vrk1GT3/GT3 mice, leading to mild neuronal phenotypes including significant but small reduction in brain mass and motor (rotarod) impairment. Analysis of gene expression in the Vrk1GT3/GT3 cortex predicts novel roles for VRK1 in neuronal pathways including neurotrophin signaling, axon guidance and pathways implicated in the pathogenesis of ALS. Together, our studies of the partial KO Vrk1 mice reveal that even moderately reduced levels of Vrk1 expression result in minor neurological impairment and indicate new neuronal pathways likely involving VRK1.
引用
收藏
相关论文
共 138 条
[31]  
Traktman P(2012)Co-ordination of cell cycle and differentiation in the developing nervous system The Biochemical journal 444 392-230
[32]  
Schober CS(2011)Rb/E2F regulates expression of neogenin during neuronal migration Molecular and cellular biology 31 166-262
[33]  
Aydiner F(2007)Cell cycle molecules define a pathway required for neuron death in development and disease Biochimica et biophysica acta 1772 266-427
[34]  
Booth CJ(2011)DNA repair deficiency in neurodegeneration Progress in neurobiology 94 1545-490
[35]  
Seli E(2014)DNA damage and its links to neurodegeneration Neuron 83 211-245
[36]  
Reinke V(2006)Neurotrophin-regulated signalling pathways Philosophical transactions of the Royal Society of London. Series B, Biological sciences 361 215-427
[37]  
Choi YH(2003)Neurotrophins and neurodegeneration Neuropathology and applied neurobiology 29 424-251
[38]  
Kim J(2012)The complex molecular biology of amyotrophic lateral sclerosis (ALS) Progress in molecular biology and translational science 107 487-173
[39]  
Choi YH(2007)Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection Biochemical Society transactions 35 239-790
[40]  
Chang S(1998)Tissue nerve growth factor concentrations in neuromuscular diseases European journal of neurology 5 419-301